News About: Pharm. Industry
Lee Jong-kap named managing director of Guerbet KoreaLee Jong-kap has been named managing director of Guerbet Korea, the company said Tuesday.
Lee, 50, will be solely responsible for marketing all contrast media to be used in M...
|
KPMA to toughen regulations on drug price dumping
The Korea Pharmaceutical Manufacturers Association (KPMA) Monday reaffirmed to toughen the punishment on those member companies who violate the rule in hospital biddings to create more fair business atmosphere.
The...
Land in Daegu’s medical complex to be put on sale
Daegu City said Monday a medical complex land in Daegu’s Shinseo district will be put on sale between September 4 and 10.
The total area to be sold is 202,000 square meters, and its land price per 3.3 square meters...
Website to provide information on GMP
A local organization will establish a website to provide key information on GMP (Good Manufacturing Practice) here in the middle of September
The website (www.bvc.co.kr) to be operated by the Validation Associatio...
Green Cross ranks first in sales per capita
Average sales per capita by 54 listed pharmaceutical companies came to 164 million won in the first half of this year, according to a market information provider Yakup.com.
Sales per capita are used for gauging emp...
Local drug makers boosting R&D spending
Korea’s pharmaceutical companies have been spending more on research and development (R&D) projects to strengthen their technology leadership, industry data showed Monday.
Pharmaceutical information provider Yakup....
Government to spend 146 billion won to support drug firms
The government unveiled a set of plans last Thursday to nurture 12 globally competitive pharmaceutical companies by 2020.
The plans are intended to develop Korea into the seventh-largest power in the industry.
...
Four in 10 customers buy functional health foods for their health
About four out of 10 customers select health foods for their own health, a survey showed Monday.
The Appletri KimYasane said its recent survey of 113 adults showed 35 percent of the respondents said they buy health...
European business delegation to promote partnership in Korea
With the EU-Korea free trade agreement having entered into force on 1 July 2011, market entry barriers have been lowered, including for medical devices.
European companies can now enjoy easier access to the Korean...
New combination drug joins domestic type 2 diabetes market
Kombiglyze XR, a combined formulation of metformin and saxagliptin, has recently joined the arsenal of drugs available to treat type 2 diabetes, according to Bristol-Myers Squibb Korea and AstraZeneca Korea.
The dr...
